Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy

Penile cancer is a rare genitourinary malignancy which can be treated with surgery or radiation for localized disease, but often requires systemic treatment with chemotherapy for recurrent or metastatic disease. With the emergence of immune checkpoint inhibitors and targeted therapies for specific g...

Full description

Saved in:
Bibliographic Details
Main Authors: David J. Benjamin, Robert C. Hsu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1457006/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841527920912236544
author David J. Benjamin
Robert C. Hsu
author_facet David J. Benjamin
Robert C. Hsu
author_sort David J. Benjamin
collection DOAJ
description Penile cancer is a rare genitourinary malignancy which can be treated with surgery or radiation for localized disease, but often requires systemic treatment with chemotherapy for recurrent or metastatic disease. With the emergence of immune checkpoint inhibitors and targeted therapies for specific genomic aberrations in the treatment of over a dozen other cancers, recent studies have sought to identify therapies other than chemotherapy in treating this uncommon cancer. Several ongoing trials involving immune checkpoint inhibitors, tyrosine kinase inhibitors, and antibody drug conjugates are attempting to identify additional therapies.
format Article
id doaj-art-acd174a198fb4d378544812173647bd4
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-acd174a198fb4d378544812173647bd42025-01-15T05:10:27ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.14570061457006Treatment approaches in advanced penile cancer: targeted therapies and immunotherapyDavid J. Benjamin0Robert C. Hsu1Department of Medical Oncology, Hoag Family Cancer Institute, Newport Beach, CA, United StatesDepartment of Internal Medicine, Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United StatesPenile cancer is a rare genitourinary malignancy which can be treated with surgery or radiation for localized disease, but often requires systemic treatment with chemotherapy for recurrent or metastatic disease. With the emergence of immune checkpoint inhibitors and targeted therapies for specific genomic aberrations in the treatment of over a dozen other cancers, recent studies have sought to identify therapies other than chemotherapy in treating this uncommon cancer. Several ongoing trials involving immune checkpoint inhibitors, tyrosine kinase inhibitors, and antibody drug conjugates are attempting to identify additional therapies.https://www.frontiersin.org/articles/10.3389/fonc.2024.1457006/fullpenile cancertargeted therapyimmune checkpoint inhibitorantibody drug conjugatevaccine
spellingShingle David J. Benjamin
Robert C. Hsu
Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
Frontiers in Oncology
penile cancer
targeted therapy
immune checkpoint inhibitor
antibody drug conjugate
vaccine
title Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
title_full Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
title_fullStr Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
title_full_unstemmed Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
title_short Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
title_sort treatment approaches in advanced penile cancer targeted therapies and immunotherapy
topic penile cancer
targeted therapy
immune checkpoint inhibitor
antibody drug conjugate
vaccine
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1457006/full
work_keys_str_mv AT davidjbenjamin treatmentapproachesinadvancedpenilecancertargetedtherapiesandimmunotherapy
AT robertchsu treatmentapproachesinadvancedpenilecancertargetedtherapiesandimmunotherapy